Logo image of DXLG

DESTINATION XL GROUP INC (DXLG) Stock Fundamental Analysis

NASDAQ:DXLG - Nasdaq - US25065K1043 - Common Stock - Currency: USD

1.27  -0.04 (-3.05%)

Fundamental Rating

3

Taking everything into account, DXLG scores 3 out of 10 in our fundamental rating. DXLG was compared to 123 industry peers in the Specialty Retail industry. While DXLG seems to be doing ok healthwise, there are quite some concerns on its profitability. DXLG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year DXLG has reported negative net income.
In the past year DXLG had a positive cash flow from operations.
DXLG had positive earnings in 4 of the past 5 years.
Of the past 5 years DXLG 4 years had a positive operating cash flow.
DXLG Yearly Net Income VS EBIT VS OCF VS FCFDXLG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M

1.2 Ratios

The Return On Assets of DXLG (-0.70%) is comparable to the rest of the industry.
With a Return On Equity value of -1.90%, DXLG perfoms like the industry average, outperforming 51.22% of the companies in the same industry.
Industry RankSector Rank
ROA -0.7%
ROE -1.9%
ROIC N/A
ROA(3y)11.33%
ROA(5y)6.65%
ROE(3y)28.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DXLG Yearly ROA, ROE, ROICDXLG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 1K 1.5K

1.3 Margins

DXLG's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of DXLG has declined.
DXLG has a better Gross Margin (45.75%) than 73.17% of its industry peers.
In the last couple of years the Gross Margin of DXLG has grown nicely.
DXLG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.75%
OM growth 3Y-54.99%
OM growth 5YN/A
PM growth 3Y-61.23%
PM growth 5YN/A
GM growth 3Y-2.03%
GM growth 5Y1.54%
DXLG Yearly Profit, Operating, Gross MarginsDXLG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

DXLG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DXLG has less shares outstanding
DXLG has more shares outstanding than it did 5 years ago.
There is no outstanding debt for DXLG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DXLG Yearly Shares OutstandingDXLG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
DXLG Yearly Total Debt VS Total AssetsDXLG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 1.30, we must say that DXLG is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.30, DXLG is not doing good in the industry: 69.92% of the companies in the same industry are doing better.
There is no outstanding debt for DXLG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.3
ROIC/WACCN/A
WACC9.43%
DXLG Yearly LT Debt VS Equity VS FCFDXLG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

DXLG has a Current Ratio of 1.45. This is a normal value and indicates that DXLG is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.45, DXLG perfoms like the industry average, outperforming 57.72% of the companies in the same industry.
DXLG has a Quick Ratio of 1.45. This is a bad value and indicates that DXLG is not financially healthy enough and could expect problems in meeting its short term obligations.
DXLG has a Quick ratio (0.46) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.46
DXLG Yearly Current Assets VS Current LiabilitesDXLG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

DXLG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -113.16%.
Measured over the past years, DXLG shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -60.46% on average per year.
The Revenue for DXLG has decreased by -10.70% in the past year. This is quite bad
Measured over the past years, DXLG shows a decrease in Revenue. The Revenue has been decreasing by -0.30% on average per year.
EPS 1Y (TTM)-113.16%
EPS 3Y-60.46%
EPS 5YN/A
EPS Q2Q%-166.67%
Revenue 1Y (TTM)-10.7%
Revenue growth 3Y-2.57%
Revenue growth 5Y-0.3%
Sales Q2Q%-8.62%

3.2 Future

The Earnings Per Share is expected to grow by 28.24% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 4.24% on average over the next years.
EPS Next Y-385.6%
EPS Next 2Y-73.78%
EPS Next 3Y12.61%
EPS Next 5Y28.24%
Revenue Next Year-5.39%
Revenue Next 2Y-1.02%
Revenue Next 3Y1.76%
Revenue Next 5Y4.24%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DXLG Yearly Revenue VS EstimatesDXLG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
DXLG Yearly EPS VS EstimatesDXLG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DXLG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DXLG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DXLG Price Earnings VS Forward Price EarningsDXLG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

99.19% of the companies in the same industry are more expensive than DXLG, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.87
DXLG Per share dataDXLG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

DXLG's earnings are expected to grow with 12.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-73.78%
EPS Next 3Y12.61%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DXLG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DESTINATION XL GROUP INC

NASDAQ:DXLG (8/15/2025, 8:16:35 PM)

1.27

-0.04 (-3.05%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-29 2025-05-29/bmo
Earnings (Next)08-27 2025-08-27/bmo
Inst Owners81.17%
Inst Owner Change-1.92%
Ins Owners6.27%
Ins Owner Change2.1%
Market Cap68.35M
Analysts80
Price Target1.68 (32.28%)
Short Float %2.72%
Short Ratio3.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-71.9%
Min EPS beat(2)-178.43%
Max EPS beat(2)34.64%
EPS beat(4)1
Avg EPS beat(4)-99.56%
Min EPS beat(4)-198.04%
Max EPS beat(4)34.64%
EPS beat(8)3
Avg EPS beat(8)-46.3%
EPS beat(12)6
Avg EPS beat(12)13.75%
EPS beat(16)10
Avg EPS beat(16)78.81%
Revenue beat(2)1
Avg Revenue beat(2)-2.22%
Min Revenue beat(2)-4.55%
Max Revenue beat(2)0.11%
Revenue beat(4)1
Avg Revenue beat(4)-4.88%
Min Revenue beat(4)-7.96%
Max Revenue beat(4)0.11%
Revenue beat(8)1
Avg Revenue beat(8)-3.81%
Revenue beat(12)3
Avg Revenue beat(12)-2.15%
Revenue beat(16)6
Avg Revenue beat(16)0.38%
PT rev (1m)0%
PT rev (3m)-22.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20%
EPS NY rev (1m)0%
EPS NY rev (3m)3.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF N/A
P/OCF 3.66
P/B 0.49
P/tB 0.49
EV/EBITDA 1.87
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.35
OCFY27.33%
SpS8.49
BVpS2.61
TBVpS2.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.7%
ROE -1.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.75%
FCFM N/A
ROA(3y)11.33%
ROA(5y)6.65%
ROE(3y)28.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.64%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-54.99%
OM growth 5YN/A
PM growth 3Y-61.23%
PM growth 5YN/A
GM growth 3Y-2.03%
GM growth 5Y1.54%
F-Score4
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 200.9%
Cap/Sales 6.26%
Interest Coverage N/A
Cash Conversion 171.47%
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 0.46
Altman-Z 1.3
F-Score4
WACC9.43%
ROIC/WACCN/A
Cap/Depr(3y)129.45%
Cap/Depr(5y)87.74%
Cap/Sales(3y)3.68%
Cap/Sales(5y)2.68%
Profit Quality(3y)77.62%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-113.16%
EPS 3Y-60.46%
EPS 5YN/A
EPS Q2Q%-166.67%
EPS Next Y-385.6%
EPS Next 2Y-73.78%
EPS Next 3Y12.61%
EPS Next 5Y28.24%
Revenue 1Y (TTM)-10.7%
Revenue growth 3Y-2.57%
Revenue growth 5Y-0.3%
Sales Q2Q%-8.62%
Revenue Next Year-5.39%
Revenue Next 2Y-1.02%
Revenue Next 3Y1.76%
Revenue Next 5Y4.24%
EBIT growth 1Y-108.83%
EBIT growth 3Y-56.15%
EBIT growth 5YN/A
EBIT Next Year-32.52%
EBIT Next 3Y45.7%
EBIT Next 5Y35.09%
FCF growth 1Y-121.07%
FCF growth 3Y-70.2%
FCF growth 5Y-4.97%
OCF growth 1Y-67.37%
OCF growth 3Y-26.84%
OCF growth 5Y13.36%